Print Page   |   Contact Us   |   Sign In   |   Join Today
News & Press: General

Eyes on Washington: Federal Health Care Grant Notification Service

Tuesday, May 19, 2015   (0 Comments)
Posted by: TCAA Staff
Share |

Eyes on Washington: Federal Health Care Grant Notification Service

 

Grant Opportunities for May 11, 2015 through May 15, 2015

 

Visit Holland & Knight online

 

New Federal Health Care Grant Opportunities Announced for:

·         Administration for Children and Families (ACF)

·         Administration for Community Living (ACL)

·         Food and Drug Administration (FDA)

·         US Army Medical Research Acquisition Activity (USAMRAA)

·         National Institutes of Health (NIH)

 

 

NON-NIH Funding Opportunity Announcements:

 

ACF: Community Services Block Grant (CSBG) Training and Technical Assistance (T/TA) Program

Funding Opportunity Number: HHS-2015-ACF-OCS-ET-1006

This Funding Opportunity Announcement (FOA) solicits applications for a Community Services Block Grant (CSBG) Learning Communities Resource Center (LCRC). The LCRC will continue to build the long-term capacity of training and technical assistance (T/TA) for CSBG by promoting and convening learning communities to improve access to validated T/TA information and resources. The LCRC will help State CSBG Lead Agencies, CSBG-eligible entities, the Regional Performance Innovation Consortium (RPIC), and other national partners by supporting activities and services that improve program outcomes within the CSBG Network. The LCRC will continue to work to improve the validity, quality, and quantity of T/TA information and resources available within the CSBG Network to help alleviate the causes and conditions of poverty in communities. In addition, this cooperative agreement will fund the creation of a new learning cluster focused specifically on alleviating child poverty in rural communities and expanding access to two generation service delivery approaches. This funding opportunity was announced on May 14, 2015. The application deadline is July 13, 2015. For more information, please visit ACF's Full Funding Opportunity Announcement.

 

ACF: Community Services Block Grant (CSBG) State and Eligible Entity Technical Assistance Services

Funding Opportunity Number: HHS-2015-ACF-OCS-ET-1007

This Funding Opportunity Announcement (FOA) solicits applications to support the Community Services Block Grant (CSBG) State and Eligible Entity Technical Assistance Services (SEETAS). The efforts supported through this cooperative agreement will focus on specialized training and technical assistance (T/TA) to meet the needs of the CSBG Network. All T/TA will be designed to develop and improve practices, activities, and services that maximize the resources of CSBG-eligible entities. The CSBG State and Eligible Entity Technical Assistance Services will increase the use of innovative, effective, and legally sound risk mitigation efforts, quality improvement support, capacity development policies, and operational procedures that support efforts to help ensure accountability and sustainability within the CSBG Network. This funding opportunity was announced on May 14, 2015. The application deadline is July 13, 2015. For more information, please visit ACF's Full Funding Opportunity Announcement.

 

 

 

 

 

ACF: Head Start and/or Early Head Start in Selected Counties in Montana

Funding Opportunity Number: HHS-2015-ACF-OHS-CH-R08-1015

This Funding Opportunity Announcement (FOA) solicits applications to provide a high-quality, comprehensive birth-to-five program incorporating both Head Start and Early Head Start funding, or to provide for Head Start only or Early Head Start only, to children and families residing in Granite, Mineral, Missoula, Powell, and Sanders Counties, Montana. This funding opportunity was announced on May 14, 2015. The application deadline is July 13, 2015. For more information, please visit ACF's Full Funding Opportunity Announcement.

 

ACF: Head Start and/or Early Head Start in Darlington County, South Carolina

Funding Opportunity Number: HHS-2015-ACF-OHS-CH-R04-1014

This Funding Opportunity Announcement (FOA) solicits applications to provide a high-quality, comprehensive birth-to-five program incorporating both Head Start and Early Head Start funding, or to provide for Head Start only or Early Head Start only, to children and families residing in Darlington County, South Carolina. This funding opportunity was announced on May 13, 2015. The application deadline is July 13, 2015. For more information, please visit ACF's Full Funding Opportunity Announcement.

 

ACF: Head Start and/or Early Head Start in the Municipalities of Loiza, Rio Grande, Luquillo, Canovanas, Farjardo, Ceiba, and Naguabo, Puerto Rico

Funding Opportunity Number: HHS-2015-ACF-OHS-CH-R02-1013

This Funding Opportunity Announcement (FOA) solicits applications to provide a high-quality, comprehensive birth-to-five program incorporating both Head Start and Early Head Start funding, or to provide for Head Start only or Early Head Start only, to children and families residing in the Municipalities of Loiza, Rio Grande, Luquillo, Canovanas, Farjardo, Ceiba, and Naguabo, Puerto Rico. This funding opportunity was announced on May 13, 2015. The application deadline is July 13, 2015. For more information, please visit ACF's Full Funding Opportunity Announcement.

 

ACF: Early Head Start in the Municipalities of Moca and San Sebastian, Puerto Rico

Funding Opportunity Number: HHS-2015-ACF-OHS-CH-R02-1012

This Funding Opportunity Announcement (FOA) solicits applications to provide Early Head Start services to infants, toddlers, pregnant women, and their families residing in the Municipalities of Moca and San Sebastian, Puerto Rico. This funding opportunity was announced on May 13, 2015. The application deadline is July 13, 2015. For more information, please visit ACF's Full Funding Opportunity Announcement.

 

ACF: Head Start and/or Early Head Start in the City of Asheville, the Town of Woodfin, and the Communities of Emma and Johnston, North Carolina

Funding Opportunity Number: HHS-2015-ACF-OHS-CH-R04-1103

This Funding Opportunity Announcement (FOA) solicits applications to provide a high-quality, comprehensive birth-to-five program incorporating both Head Start and Early Head Start funding, or to provide for Head Start only or Early Head Start only, to children and families residing in the City of Asheville, the Town of Woodfin, and the Communities of Emma, and Johnston, North Carolina. This funding opportunity was announced on May 13, 2015. The application deadline is July 13, 2015. For more information, please visit ACF's Full Funding Opportunity Announcement.

 

ACL: National Minority Aging Organizations (NMAO) Technical Assistance Centers

Funding Opportunity Number: HHS-2015-ACL-AOA-HD-0097

The purpose of this Funding Opportunity Announcement (FOA) is to establish a National Consortium on Aging Resources for Senior Equity (Consortium) that is capable of providing technical assistance to to the Aging Network. The Consortium will be charged with three primary objectives: (1) continue building the competence of mainstream aging services organizations to better respond to the needs of older racial and ethnic minority and LGBT individuals; (2) develop and disseminate training and technical assistance to racial and ethnic minority and LGBT national and community organizations that will enable them to better recognize the needs of older individuals; and (3) identify and develop training and technical assistance strategies and/or materials for older racial and ethnic minority and LBGT individuals. The Consortium work will build on decades of experience targeting special populations, identifying need, barriers to service and identifying appropriate strategies to meet those needs. Further, the Consortium will be charged with identifying and tailoring informational materials and innovative strategies designed in a culturally competent manner to alert racial, ethnic minority and LBGT older individuals and their families how to prevent financial exploitation. This funding opportunity was announced on May 14, 2015. The application deadline is June 15, 2015. For more information, please visit ACL's Full Funding Opportunity Announcement.

 

FDA: Evaluating Quality Metrics for Risk-Based Surveillance of Drug Manufacturing Operations and Facilities

Funding Opportunity Number: RFA-FD-15-036

The goal of this project is to evaluate a set of potential quality metrics for their utility in monitoring quality across the pharmaceutical manufacturing sector. This project supports the FDA's efforts transform quality oversight from a qualitative to a quantitative and expertise-based assessment in order to assure that quality drugs are available to the American public. The outcomes of the project could also be used to assist in the development of a risk-based inspection approach for domestic and foreign drug establishments. This funding opportunity was announced on May 14, 2015. The application deadline is July 2, 2015. For more information, please visit FDA's Full Funding Opportunity Announcement.

 

USAMRAA: Gulf War Illness Innovative Treatment Evaluation Award

Funding Opportunity Number: W81XWH-15-GWIRP-ITEA

The Innovative Treatment Evaluation Award mechanism supports the early systematic evaluation of innovative interventions with the potential to impact the health and lives of Veterans with Gulf War Illness (GWI). The results of preliminary studies funded by this award should have the potential to provide clinical proof-of-principle data and support future development of broader efficacy studies of the proposed interventions. An application may demonstrate innovation not only by investigating a novel therapeutic approach for GWI, but also by studying a treatment that may have been utilized for other chronic multi-symptom illnesses, but has not yet been studied in Veterans with GWI. For example, a pharmacological treatment or nutritional supplement suggested by previous research to be beneficial for fibromyalgia or chronic fatigue syndrome could be evaluated in Veterans with GWI. However, the focus of the research must be clearly on GWI (and Veterans of the 1990-1991 Gulf War) and not on another disease process or Veteran cohort. Given the emphasis on innovation in the Innovative Treatment Evaluation Award, applications are not required to include preliminary data. If preliminary data are provided, the data do not necessarily have to come from the GWI research field. Whether or not preliminary data are included in the application, the proposed research project should be based on sound scientific rationale that is established through logical reasoning and critical review and analysis of the literature. Trials of treatments or interventions for which considerable preliminary and/or preclinical data have been developed should be proposed under the Clinical Trial Award. This funding opportunity was announced on May 14, 2015. The application deadline is October 29, 2015. For more information, please visit the Army's Full Funding Opportunity Announcement.

 

USAMRAA: Gulf War Illness Clinical Trial Award

Funding Opportunity Number: W81XWH-15-GWIRP-CTA

The Clinical Trial Award supports execution of clinical trials with the potential to have a significant impact on the health and lives of Veterans with Gulf War Illness (GWI). Health outcomes of interest should include improvements in overall functional status or in symptom complexes, both individually and/or as they may interact with each other. Proposed studies may be single-center or multi-center clinical trials. Applications may be submitted by a single Principal Investigator (PI) or by a team of investigators led by an Initiating PI with up to three Partnering PIs. The Multiple PI Option is structured so that up to four investigators, each of whom will be designated “PI” and receive a separate award, will work synergistically on a single project. One member of the team will be identified as the Initiating PI and will be responsible for the majority of the administrative tasks associated with the application. The other member(s) will be referred to as the Partnering PI(s). All the investigators must collaborate to submit a single project examining one or more treatment modalities or comparing untested or novel treatments for GWI symptoms. It should be clear that all investigators have an appropriate level of intellectual input and effort. The Initiating PI should have demonstrated expertise in GWI research, while the Partnering PIs may contribute expertise from a different field that can be applied to GWI. Multidisciplinary and multi-organizational projects are encouraged. If the project is multi-organizational, applications should include plans for communication between investigators at each organization. Additionally, participating organizations must be willing to resolve potential intellectual and material property issues and to remove any barriers that might interfere with achieving high levels of cooperation to ensure successful completion of the project. This funding opportunity was announced on May 14, 2015. The application deadline is October 29, 2015. For more information, please visit the Army's Full Funding Opportunity Announcement.

 

USAMRAA: Gulf War Illness Epidemiology Research Award

Funding Opportunity Number: W81XWH-15-GWIRP-GWIERA

The purpose of this award is to support population-based research to obtain a better understanding of mortality, morbidity, and symptomatology over time in Veterans deployed in the 1990-1991 Persian Gulf War and afflicted by Gulf War Illness (GWI). While individual symptoms experienced by ill Gulf War Veterans can vary from person to person, the types of symptoms reported are comparable and typically include some combination of widespread pain and headaches, fatigue, cognitive impairment, gastrointestinal symptoms, and skin abnormalities. GWI case definitions published to date may be improved through the consideration of additional epidemiological data describing symptom onset, duration, severity, and laboratory findings. The Gulf War Illness Epidemiology Research Award will support hypothesis-driven or discovery-based research into mortality, morbidity, and symptomatology and/or how these have changed or progressed over time in the Gulf War Veteran population compared to rates and patterns of change with time in appropriate control populations. Topic areas of interest include but are not limited to (1) mortality, (2) descriptors of symptomatology and changes to those associated with GWI, (3) clinical diagnoses and laboratory findings, (4) symptom clustering and subgrouping, and (5) gender and racial differences. Studies proposed under this award may also address questions related to medical conditions co-occurring with GWI or related to Gulf War Veteran offspring; however, the primary focus of the study must be epidemiological characterization of the Gulf War Veteran population. This funding opportunity was announced on May 14, 2015. The application deadline is October 29, 2015. For more information, please visit the Army's Full Funding Opportunity Announcement.

 

USAMRAA: Gulf War Illness Investigator-Initiated Research Award

Funding Opportunity Number: W81XWH-15-GWIRP-IIRA

The purpose of the Investigator-Initiated Research Award is to encourage basic through clinical research aimed at identification of objective measures (e.g., biomarkers) to distinguish healthy Veterans from those with GWI, or improve understanding of the pathobiology underlying symptoms associated with GWI. The Investigator-Initiated Research Award is designed to promote new ideas in GWI research and establish proof of principle for further development in future studies. Applications are not required to include preliminary data; however, preliminary data may be used to support the objectives of an application. These data are not required to have come from the GWI research field. Applications not supported by preliminary data should be based on sound scientific rationale and may reflect clinical observations or seek to evaluate discoveries made in relation to other chronic multi-symptom illnesses for their application in GWI. Regardless of the approach, the focus should be clearly on Veterans with GWI. It is the responsibility of the Principal Investigator (PI) to clearly and explicitly articulate the project’s potential impact on GWI. Studies that characterize chronic effects of neurotoxic exposures at dosages comparable to that encountered in-theatre during the Gulf War are of interest. Studies using animal models should focus on long-term and latent effects of toxic exposures to closely represent the current status of GWI patients. All studies using animal models should use an established model unless there is a compelling scientific justification for the development or use of a new model. Development of new animal models is discouraged. The Investigator-Initiated Research Award can also be used for testing of GWI-targeted pharmacologic agents in absorption, distribution, metabolism, and excretion (ADME) studies, and toxicology testing, including Investigational New Drug (IND)-enabling pharmacology/ toxicology testing. Preclinical development of non-pharmacological interventions is also acceptable. This funding opportunity was announced on May 14, 2015. The application deadline is October 29, 2015. For more information, please visit the Army's Full Funding Opportunity Announcement.

 

USAMRAA: Gulf War Illness New Investigator Research Award

Funding Opportunity Number: W81XWH-15-GWIRP-NIA

The intent of the GWIRP New Investigator Award is to support investigators new to the field of GWI research at different stages of career development. This award enables such investigators to compete for funding separately from investigators with established programs of GWI research. Previous experience in GWI research is allowed, but not required. Principal Investigators (PIs) with a limited background in GWI research are strongly encouraged to strengthen their applications through collaboration with investigators who are experienced in GWI research and/or possess other relevant expertise. It is the PI’s responsibility to describe how the collaboration(s) will augment his/her ability to address the research question. The New Investigator Award is designed to promote new ideas in GWI research and establish proof-of-principle for further development in future studies. Applications are not required to include preliminary data; however, preliminary data may be used to support the objectives of an application. These data are not required to have come from the GWI research field. Applications not supported by preliminary data should be based on sound scientific rationale and may reflect clinical observations or seek to evaluate discoveries made in relation to other chronic multi-symptom illnesses for their application in GWI. Regardless of the approach, the focus should be clearly on Veterans with GWI. It is the responsibility of the PI to clearly and explicitly articulate the project’s potential impact on GWI. This funding opportunity was announced on May 14, 2015. The application deadline is October 29, 2015. For more information, please visit the Army's Full Funding Opportunity Announcement.

 

 

NIH Funding Opportunity Announcements:

 

NIH: Human Studies to Evaluate Promising Medications to Treat Alcohol Use Disorder

Funding Opportunity Number: PA-15-254, PA-15-255, and PA-15-256

The objective of this Funding Opportunity Announcement (FOA) is to encourage applications that use human laboratory paradigms and/or clinical trials to evaluate the safety and efficacy of novel or re-purposed compounds, that bind to new targets, for treatment of alcohol use disorder (AUD) or AUD with a comorbid post-traumatic stress disorder. Alcohol use disorder (AUD) is a global health problem, affecting over 76 million adults world-wide, including over 17 million Americans, resulting in a myriad of medical, psychological, social, economic, and personal problems. AUD ranks among the leading causes of decrements in disability-adjusted life-years and ranks third in preventable causes of death in the United States. This funding opportunity was announced on May 13, 2015. The initial application deadline for PA-15-254 and PA-15-255 is October 21, 2015. The initial application deadline for PA-15-256 is October 5, 2015. A letter of intent is due 30 days prior to the application deadline. For more information, please visit NIH's Full Funding Opportunity Announcements for PA-15-254, PA-15-255, and PA-15-256.

 

NIH: Provocative Questions (PQ) Initiative; Cancer with an Underlying HIV Infection

Funding Opportunity Number: RFA-CA-15-012 and RFA-CA-15-013

The purpose of these Funding Opportunity Announcements (FOAs) is to advance our understanding of the risks, development, progression, diagnosis, and treatment of malignancies observed in individuals with an underlying HIV infection or Acquired Immune Deficiency Syndrome (AIDS) through research directed at addressing one of several proposed "Provocative Questions" (PQs). These PQs are not intended to represent the full range of National Cancer Institute's priorities in HIV/AIDS-related cancer research. Rather, they are meant to challenge researchers to think about and elucidate specific problems and paradoxes in key areas of AIDS-related cancer research that are deemed important but have not received sufficient attention. These funding opportunities were announced on May 14, 2015. The initial application deadline for both opportunities is August 18, 2015. A letter of intent for each opportunity is due 30 days prior to the associated application deadline. For more information, please visit NIH's Full Funding Opportunity Announcements for RFA-CA-15-012 and RFA-CA-15-013.

 

 

 

 

NIH: NINDS Faculty Development Award to Promote Diversity in Neuroscience Research

Funding Opportunity Number: PAR-15-257

The purpose of the National Institute of Neurological Disorders and Stroke (NINDS) Faculty Development Award to Promote Diversity in Neuroscience Research is to diversify the pool of independent neuroscience research investigators and to enhance the opportunity to obtain independent NIH or other independent research support by providing junior faculty with research cost support, protected research time and career stage appropriate professional development mentorship in neuroscience research. Individuals from backgrounds underrepresented in biomedical research are eligible for support under this award if they have doctoral research degrees (Ph.D. or equivalent) and are in the first 3 years of a faculty tenure track or equivalent position at the time of award. This funding opportunity was announced on May 14, 2015. The application deadline is October 12, 2015. For more information, please visit NIH's Full Funding Opportunity Announcement.

 

NIH: Development of Measures of Fatigability in Older Adults

Funding Opportunity Number: RFA-AG-16-013

This Funding Opportunity Announcement (FOA) solicits applications to develop and evaluate measures of fatigability. Fatigue is a significant health concern for many populations across the life course including older adults and individuals with chronic illnesses such as cancer. Fatigue is the most common reason for restricting activity in previously functional community-dwelling older adults. Cancer-related fatigue (CRF) is recognized as one of the most common symptoms in patients receiving treatment for cancer, often persisting beyond the conclusion of active treatment and through the end of life. Longitudinal and comparative studies indicate that fatigue may also be a significant problem for cancer survivors, with many survivors reporting fatigue scores higher than that of an age-matched general population. We have made limited progress in delineating the pathophysiology and optimal treatment of fatigue, and there is emerging evidence to suggest that fatigue may not be a unitary phenomenon. Current therapeutic approaches targeting fatigue (for example exercise, mindfulness-based stress reduction) are non-specifically applied to a vaguely defined symptom, and treatment responses have been difficult to capture. Innovations in the conceptualization and measurement of fatigue are needed to (1) identify its distinct domains, (2) distinguish it from related phenomena such as depression, diminished cardiopulmonary reserve, or sarcopenia, (3) expand our mechanistic understanding of fatigue, and (4) identify novel targets for its treatment. This funding opportunity was announced on May 14, 2015. A letter of intent is due by September 1, 2015. The application deadline is October 1, 2015. For more information, please visit NIH's Full Funding Opportunity Announcement.

 

NIH: Administrative Supplements for Research on Dietary Supplements

Funding Opportunity Number: PA-15-258

The purpose of this Funding Opportunity Announcement (FOA) is to provide administrative supplements to support research in which the supplemental funding would investigate the role of dietary supplements and/or their ingredients in health maintenance and disease prevention. Parent awards need not be focused on dietary supplements; this FOA may provide support to include dietary supplements within the scope of relevant research projects. Research projects need not be limited to specific health conditions, organ systems or population groups. This FOA supports all types of research, including pre-clinical, clinical, behavioral, and epidemiological, as training programs that build future research capacity for studying the role of dietary supplements in health and disease prevention. Primary consideration for support will be given to applications that stimulate dietary supplement research where it is lacking or lagging, clarify gaps, opportunities and balance between benefits and risks where data are in conflict, target special population groups where additional science on dietary supplements is needed, and focus on the use of dietary supplements in improving or maintaining health and reducing the risk of chronic disease. This funding opportunity was announced on May 14, 2015. The initial application deadline is October 15, 2015. For more information, please visit NIH's Full Funding Opportunity Announcement.

 

 

 

 

NIH: Discovery of the Genetic Basis of Structural Birth Defects and of Childhood Cancers: Gabriella Miller Kids First Pediatric Research Program

Funding Opportunity Number: PAR-15-259

This Funding Opportunity Announcement (FOA) invites applications to use whole genome sequencing at an NHGRI-supported sequencing center to investigate the genetic etiology of structural birth defects, and to further elucidate the genetic contribution to childhood cancers and the genomic contributions to treatment failure for childhood sarcomas. These data will become part of a data resource for the pediatric research community. Information from this activity will be used to help design future activities of the Gabriella Miller Kids First (Kids First) Pediatric Research Program. This funding opportunity was announced on May 15, 2015. A letter of intent is due by June 27, 2015. The initial application deadline is July 27, 2015. For more information, please visit NIH's Full Funding Opportunity Announcement.

 

NIH: Clinical and Translational Science Award (CTSA) Network Recruitment Innovation Centers

Funding Opportunity Number: RFA-TR-15-004

The purpose of this Funding Opportunity Announcement (FOA) is to create Clinical and Translational Science Award (CTSA) Network Recruitment Innovation Centers (RICs) to improve participant recruitment into clinical trials by using innovative means to assess the availability of potential participants and to enroll them in a timely manner. Translating laboratory and clinical discoveries into interventions that improve human health is a complex process that typically takes years of effort. Multi-site clinical trials are a critical step in the translation pathway that allows preventive, diagnostic, or therapeutic interventions to benefit individual and public health. These trials may require substantial sample sizes to credibly test hypotheses. However, such trials often experience delays or even fail entirely due to challenges in recruiting participants. Such challenges are a multi-faceted problem with scientific, psychological, sociological, economic, political, and ethical dimensions. Addressing these challenges therefore requires a multi-faceted and “out of the box” approach, rather than small changes only to the status quo. This funding opportunity was announced on May 15, 2015. A letter of intent is due by June 22, 2015. The initial application deadline is July 22, 2015. For more information, please visit NIH's Full Funding Opportunity Announcement.

 

NIH: Behavioral Interventions to Prevent HIV in Diverse Adolescent Men Who Have Sex with Men

Funding Opportunity Number: RFA-MD-15-012

The purpose of this initiative is to test behavioral HIV prevention interventions for diverse populations of adolescent (age 13-18) men who have sex with men (MSM). Interventions may include an adaptation of an existing evidence-based intervention to be appropriate for a wider range of populations or further testing of a new intervention that has not been evaluated in a large scale, multi-site intervention trial. Projects should involve collaborations among researchers, community organizations, healthcare providers, public health organizations, consumer advocacy groups, faith-based organizations, or other relevant stakeholders with expertise in HIV prevention and research in different US population groups. It is expected that the intervention or interventions to be tested have been developed or modified with community input to be culturally sensitive and acceptable to the targeted populations. Projects that involve adolescent MSM in the conduct of the research (e.g., as peer educators, consultants, advisory board members, etc.) are strongly encouraged. This funding opportunity was announced on May 15, 2015. A letter of intent is due by December 15, 2015. The initial application deadline is January 15, 2016. For more information, please visit NIH's Full Funding Opportunity Announcement.


Association Management Software Powered by YourMembership  ::  Legal